vs

Side-by-side financial comparison of ALTISOURCE PORTFOLIO SOLUTIONS S.A. (ASPS) and RED RIVER BANCSHARES INC (RRBI). Click either name above to swap in a different company.

ALTISOURCE PORTFOLIO SOLUTIONS S.A. is the larger business by last-quarter revenue ($42.3M vs $33.2M, roughly 1.3× RED RIVER BANCSHARES INC). RED RIVER BANCSHARES INC runs the higher net margin — 34.4% vs -16.8%, a 51.2% gap on every dollar of revenue. On growth, RED RIVER BANCSHARES INC posted the faster year-over-year revenue change (15.7% vs 3.2%). RED RIVER BANCSHARES INC produced more free cash flow last quarter ($42.2M vs $-525.0K). Over the past eight quarters, RED RIVER BANCSHARES INC's revenue compounded faster (12.4% CAGR vs 3.6%).

Altisource Portfolio Solutions S.A. is a global provider of integrated technology, data and operational services for the mortgage, real estate and consumer finance sectors. It serves lenders, servicers and investors, offering solutions that streamline asset management and residential property transaction workflows to boost operational efficiency.

Red River Bancshares Inc is a U.S. regional financial holding company operating through its wholly owned subsidiary Red River Bank. It provides a full suite of retail and commercial banking products including deposit accounts, personal and commercial loans, mortgage services, and wealth management, primarily serving customers across Louisiana, with a focus on local communities and small to mid-sized enterprises.

ASPS vs RRBI — Head-to-Head

Bigger by revenue
ASPS
ASPS
1.3× larger
ASPS
$42.3M
$33.2M
RRBI
Growing faster (revenue YoY)
RRBI
RRBI
+12.5% gap
RRBI
15.7%
3.2%
ASPS
Higher net margin
RRBI
RRBI
51.2% more per $
RRBI
34.4%
-16.8%
ASPS
More free cash flow
RRBI
RRBI
$42.7M more FCF
RRBI
$42.2M
$-525.0K
ASPS
Faster 2-yr revenue CAGR
RRBI
RRBI
Annualised
RRBI
12.4%
3.6%
ASPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASPS
ASPS
RRBI
RRBI
Revenue
$42.3M
$33.2M
Net Profit
$-7.1M
$11.4M
Gross Margin
26.5%
Operating Margin
-15.5%
42.8%
Net Margin
-16.8%
34.4%
Revenue YoY
3.2%
15.7%
Net Profit YoY
18.2%
22.7%
EPS (diluted)
$-1.02
$1.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPS
ASPS
RRBI
RRBI
Q4 25
$42.3M
$33.2M
Q3 25
$41.9M
$31.9M
Q2 25
$43.3M
$30.5M
Q1 25
$43.4M
$29.9M
Q4 24
$41.0M
$28.7M
Q3 24
$40.5M
$27.9M
Q2 24
$39.1M
$26.9M
Q1 24
$39.5M
$26.3M
Net Profit
ASPS
ASPS
RRBI
RRBI
Q4 25
$-7.1M
$11.4M
Q3 25
$-2.3M
$10.8M
Q2 25
$16.7M
$10.2M
Q1 25
$-5.3M
$10.4M
Q4 24
$-8.7M
$9.3M
Q3 24
$-9.3M
$8.8M
Q2 24
$-8.3M
$8.0M
Q1 24
$-9.2M
$8.2M
Gross Margin
ASPS
ASPS
RRBI
RRBI
Q4 25
26.5%
Q3 25
27.1%
Q2 25
30.1%
Q1 25
30.7%
Q4 24
30.3%
Q3 24
29.8%
Q2 24
32.5%
Q1 24
31.2%
Operating Margin
ASPS
ASPS
RRBI
RRBI
Q4 25
-15.5%
42.8%
Q3 25
1.2%
41.9%
Q2 25
7.5%
41.7%
Q1 25
7.5%
43.0%
Q4 24
1.4%
40.2%
Q3 24
2.7%
38.8%
Q2 24
5.3%
36.8%
Q1 24
-1.4%
38.5%
Net Margin
ASPS
ASPS
RRBI
RRBI
Q4 25
-16.8%
34.4%
Q3 25
-5.5%
33.8%
Q2 25
38.5%
33.4%
Q1 25
-12.1%
34.6%
Q4 24
-21.3%
32.4%
Q3 24
-23.0%
31.4%
Q2 24
-21.1%
29.7%
Q1 24
-23.2%
31.1%
EPS (diluted)
ASPS
ASPS
RRBI
RRBI
Q4 25
$-1.02
$1.72
Q3 25
$-0.22
$1.63
Q2 25
$1.48
$1.51
Q1 25
$-0.09
$1.52
Q4 24
$-4.72
$1.36
Q3 24
$-2.61
$1.27
Q2 24
$-2.33
$1.16
Q1 24
$-0.33
$1.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPS
ASPS
RRBI
RRBI
Cash + ST InvestmentsLiquidity on hand
$26.6M
$213.4M
Total DebtLower is stronger
$191.1M
Stockholders' EquityBook value
$-110.2M
$365.1M
Total Assets
$139.8M
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPS
ASPS
RRBI
RRBI
Q4 25
$26.6M
$213.4M
Q3 25
$28.6M
$161.1M
Q2 25
$30.0M
$210.4M
Q1 25
$30.8M
$252.2M
Q4 24
$29.8M
$269.0M
Q3 24
$28.3M
$232.6M
Q2 24
$29.7M
$213.1M
Q1 24
$29.6M
$229.8M
Total Debt
ASPS
ASPS
RRBI
RRBI
Q4 25
$191.1M
Q3 25
$192.5M
Q2 25
$193.9M
Q1 25
$195.0M
Q4 24
$230.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASPS
ASPS
RRBI
RRBI
Q4 25
$-110.2M
$365.1M
Q3 25
$-104.2M
$351.3M
Q2 25
$-102.7M
$335.4M
Q1 25
$-119.8M
$333.3M
Q4 24
$-157.4M
$319.7M
Q3 24
$-149.4M
$324.3M
Q2 24
$-140.8M
$307.0M
Q1 24
$-133.3M
$299.3M
Total Assets
ASPS
ASPS
RRBI
RRBI
Q4 25
$139.8M
$3.4B
Q3 25
$139.9M
$3.2B
Q2 25
$142.9M
$3.2B
Q1 25
$145.7M
$3.2B
Q4 24
$143.6M
$3.1B
Q3 24
$144.5M
$3.1B
Q2 24
$146.6M
$3.0B
Q1 24
$148.9M
$3.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPS
ASPS
RRBI
RRBI
Operating Cash FlowLast quarter
$-505.0K
$44.8M
Free Cash FlowOCF − Capex
$-525.0K
$42.2M
FCF MarginFCF / Revenue
-1.2%
127.2%
Capex IntensityCapex / Revenue
0.0%
7.8%
Cash ConversionOCF / Net Profit
3.92×
TTM Free Cash FlowTrailing 4 quarters
$-5.1M
$75.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPS
ASPS
RRBI
RRBI
Q4 25
$-505.0K
$44.8M
Q3 25
$718.0K
$16.5M
Q2 25
$-306.0K
$3.8M
Q1 25
$-5.0M
$13.9M
Q4 24
$-1.4M
$38.3M
Q3 24
$-1.6M
$17.4M
Q2 24
$180.0K
$2.4M
Q1 24
$-2.2M
$14.4M
Free Cash Flow
ASPS
ASPS
RRBI
RRBI
Q4 25
$-525.0K
$42.2M
Q3 25
$697.0K
$15.8M
Q2 25
$-309.0K
$3.5M
Q1 25
$-5.0M
$13.7M
Q4 24
$-1.4M
$33.4M
Q3 24
$17.0M
Q2 24
$1.4M
Q1 24
$13.4M
FCF Margin
ASPS
ASPS
RRBI
RRBI
Q4 25
-1.2%
127.2%
Q3 25
1.7%
49.6%
Q2 25
-0.7%
11.6%
Q1 25
-11.5%
45.7%
Q4 24
-3.4%
116.5%
Q3 24
60.9%
Q2 24
5.4%
Q1 24
50.8%
Capex Intensity
ASPS
ASPS
RRBI
RRBI
Q4 25
0.0%
7.8%
Q3 25
0.1%
2.1%
Q2 25
0.0%
0.9%
Q1 25
0.1%
0.9%
Q4 24
0.0%
17.0%
Q3 24
0.0%
1.4%
Q2 24
0.0%
3.6%
Q1 24
0.0%
4.0%
Cash Conversion
ASPS
ASPS
RRBI
RRBI
Q4 25
3.92×
Q3 25
1.53×
Q2 25
-0.02×
0.37×
Q1 25
1.34×
Q4 24
4.11×
Q3 24
1.99×
Q2 24
0.30×
Q1 24
1.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASPS
ASPS

Services$39.9M94%
Revenue Relatedto Technology Platformsand Professional Services$2.4M6%

RRBI
RRBI

Segment breakdown not available.

Related Comparisons